Volume | 440,062 |
|
|||||
News | - | ||||||
Day High | 237.54 | Low High |
|||||
Day Low | 232.42 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
IQVIA Holdings Inc | IQV | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
236.85 | 232.42 | 237.54 | 240.84 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,601 | 440,062 | $ 233.53 | $ 102,767,120 | - | 167.42 - 261.73 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:29:48 | 3,630 | $ 232.6301 | USD |
IQVIA (IQV) Options Flow Summary
IQVIA Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
42.33B | 181.50M | - | 14.98B | 1.36B | 7.48 | 31.17 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
IQVIA News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IQV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 225.19 | 244.27 | 222.71 | 234.96 | 952,294 | 7.44 | 3.30% |
1 Month | 252.71 | 253.84 | 222.71 | 238.08 | 780,922 | -20.08 | -7.95% |
3 Months | 207.90 | 261.73 | 205.38 | 240.31 | 947,001 | 24.73 | 11.90% |
6 Months | 183.67 | 261.73 | 167.42 | 220.97 | 1,096,571 | 48.96 | 26.66% |
1 Year | 202.67 | 261.73 | 167.42 | 213.32 | 1,102,603 | 29.96 | 14.78% |
3 Years | 233.09 | 285.61 | 165.75 | 221.53 | 1,014,006 | -0.4599 | -0.20% |
5 Years | 135.80 | 285.61 | 81.79 | 189.63 | 1,109,961 | 96.83 | 71.30% |
IQVIA Description
IQVIA Holdings Inc is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. |